pharma news today obesity drug glp-1 drugs such as semaglutide and tirzepatide are transforming and diabetes care in India, but experts warn that improper use could lead to significant muscle loss. A new India-specific consensus highlights GLP-1 Market Expected to More

An AI system may see Ozempic, Wegovy, semaglutide, Mounjaro, tirzepatide, weight loss injection, and diabetes medicine and treat them as interchangeable

Diabetes type 2 has a high prevalence in the obese (BMI 25kg/m 2 ) and overweight (BMI 30kg/m 2 ) population, and these patients tend to have poor diets and sedentary lifestyles

To overcome this, we prioritise advanced delivery methods

The study received ethical approval from the Regional and Institutional Committee of Science and Research Ethics of the Scientific Council of Health (ETT TUKEB 15032/2019/EKU) and was conducted in adherence to the principles of the Declaration of Helsinki

Epilepsia 1994, 35: 1005-1015